Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting.
Achmad H, Saleh Ibrahim Y, Mohammed Al-Taee M, Gabr GA, Waheed Riaz M, Hamoud Alshahrani S, Alexis Ramírez-Coronel A, Turki Jalil A, Setia Budi H, Sawitri W, Elena Stanislavovna M, Gupta J.
Achmad H, et al.
Int Immunopharmacol. 2022 Dec;113(Pt B):109434. doi: 10.1016/j.intimp.2022.109434. Epub 2022 Nov 16.
Int Immunopharmacol. 2022.
PMID: 36402068
Review.